IKS Health has granted 46,000 employee stock options to eligible employees under its Employee Stock Option Plan 2022 (IKS ESOP Plan). This decision, approved on December 24, 2025, aims to incentivize and retain talent. Each option converts into one equity share with a face value of Re. 1. The options are priced at Rs. 1,749.00 per option.
ESOP Grant Details
IKS Health has approved the grant of 46,000 employee stock options to its eligible employees as of December 24, 2025. These options are granted under the company’s Employee Stock Option Plan 2022 (IKS ESOP Plan).
Key Highlights of the ESOP
Here are the notable features of the employee stock options granted:
- Number of Options Granted: 46,000
- Conversion: Each option is convertible into one fully paid-up equity share.
- Face Value: Each equity share has a face value of Re. 1.
- Exercise Price: The options are granted at an exercise price of Rs. 1,749.00 per option.
- Market Price Reference: The exercise price is not less than the market price, specifically the closing price on December 23, 2025, on the National Stock Exchange of India Limited.
- Exercise Period: The stock options can be exercised anytime during continuous active employment from the date of vesting.
Additional Terms
The IKS ESOP Plan is being administered through a Trust. When exercised, each option will be converted into one equity share with a face value of Re.1. The scheme also provides guidelines for handling stock options in various circumstances, including death, permanent incapacity, resignation, and retirement. Adjustments will be made for corporate actions like rights issues and mergers, ensuring fairness under the IKS ESOP Plan. Allotted equity shares are not subject to a lock-in period.
Source: BSE